Nanoparticle transport pathways into tumors
Source abstract
Abstract
Two transport pathways (interendothelial and transendothelial routes) have long been proposed for entry of nanoparticles from the blood circulation into solid tumors. We examine and discuss available evidence supporting interendothelial and transendothelial transport processes and suggest new avenues for re-evaluating these pathways. Understanding of integrative mechanisms controlling nanoparticle extravasation into tumors is important for improving engineering and performance of anti-cancer nanopharmaceuticals.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoparticles: synthesis and applications · Iron oxide chemistry and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (32)
Show source-provided references
1. Anchordoquy TJ, Barenholz Y, Boraschi D, Chorny M, Decuzzi P, Dobrovolskaia MA, Farhangrazi ZS, Farrell D, Gabizon A, Ghandehari H, Godin B, La-Beck NM, Ljubimova J, Moghimi SM, Pagliaro L, Park J-H, Peer D, Ruoslahti E, Serkova NJ, Simberg D (2017) Mechanisms and barriers in cancer nanomedicine: addressing challenges, looking for solutions. ACS Nano 11:12–1810.1021/acsnano.6b08244 ↗
2. Bjornholm M, Thurecht KJ, Michael M, Scott AM, Caruso F (2017) Bridging bio—nano science and cancer nanomedicine. ACS Nano 11:9594–961310.1021/acsnano.7b04855 ↗
3. Cabral H, Matsumoto Y, Mizuno K, Chen Q, Murakami M, Kimura M, Terada Y, Kano MR, Miyazono K, Uesaka M, Nishiyama N, Kataoka K (2011) Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol 6:815–82310.1038/nnano.2011.166 ↗
4. Chauhan VP, Stylianopoulos T, Martin JD, Popovic Z, Chen O, Kamoun WS, Bawendi MG, Fukumura D, Jain RK (2012) Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner. Nat Nanotechnol 7:383–38810.1038/nnano.2012.45 ↗
5. Daemen T, Veliniva MJ, Regts J, de Jager M, Kalicharan R, Donga J, can der Want JJ, Scherphof GL (1997) Different intrahepatic distribution of phosphatidylglycerol and phosphatidylserine liposomes in the rat. Hepatology 26:416–42310.1002/hep.510260223 ↗
6. DvoraK am, Feng D (2001) The vesiculo-vacular organelle (VVO): a new endothelial cell permeability organelle. J Histochem Cytochem 49:419–43110.1177/002215540104900401 ↗
7. Fang J, Nakamura MH (2011) The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 63:136–15110.1016/j.addr.2010.04.009 ↗
8. Gerlowski LE, Jain RK (1986) Microvascular permeability of normal and neoplastic tissues. Microvasc Res 31:288–30510.1016/0026-2862(86)90018-X ↗
9. Griffin JI, Wang G, Smith WJ, Vu VP, Scheinman R, Stitch D, Moldovan R, Moghimi SM, Simberg D (2017) Revealing dynamics of accumulation of systemically injected liposomes in the skin by intravital microscopy. ACS Nano 11:11584–1159310.1021/acsnano.7b06524 ↗
10. Hansen AE, Petersen AL, Henriksen JR, Boerresen B, Rasmussen P, Elema DR, Munck af Rosenschold P, Kristensen AT, Kjaer A, Andresen TL (2015) Positron emission tomography based elucidation of the enhanced permeability and retention effect in dogs with cancer using copper-64 liposomes. ACS Nano 9:6985–699510.1021/acsnano.5b01324 ↗
11. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A 95:3607–361210.1073/pnas.95.8.4607 ↗
12. Huang SK, Martin FJ, Jay G, Vogel J, Papahadjopoulos D, Friend DS (1993) Extravasation and transcytosis of liposomes in Kaposi’s sarcoma-like dermal lesions of transgenic mice bearing the HIV tat gene. Am J Pathol 143:10–14
13. Key J, Palange AL, Gentile F, Aryal S, Stigliano C, Di Mascolo D, De Rosa E, Cho M, Lee Y, Singh J, Decuzzi P (2015) Soft discoidal polymeric nanoconstructs resist macrophage uptake and enhance vascular targeting in tumors. ACS Nano 9:11628–1164110.1021/acsnano.5b04866 ↗
14. Lee T-R, Chai M, Kopacz AM, Yun S-H, Liu WK, Decuzzi P (2013) On the near-wall accumulation of injectable particles in the microcirculation: smaller is not better. Sci Rep 3:207910.1038/srep02079 ↗
15. Liu X, Lin P, Perrett I, Lin J, Liao YP, Chang CH, Jiang J, Wu N, Donahue T, Wainberg Z, Nel A, Meng H (2017) Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer. J Clin Invest 127:2007–201810.1172/JCI92284 ↗
16. Matsumoto Y, Nichols JW, Toh K, Nomoto T, Cabral H, Miura Y, Christie RJ, Yamada N, Ogura T, Kano MR, Matsumura Y, Nishiyama N, Yamasoba T, Bae YH, Kataoka K (2016) Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery. Nat Nanotechnol 11:533–53810.1038/nnano.2015.342 ↗
17. Matsumura Y, Maeda H (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smacs. Cancer Res 36:6387–6392
18. Moghimi SM, Farhangrazi ZS (2014) Just do stories: the random act of anti-cancer nanomedicine performance. Nanomedicine 10:1661–166610.1016/j.nano.2014.04.011 ↗
19. Moghimi SM, Hunter AC, Andresen TL (2012) Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective. Annu Rev Pharmacol Toxicol 52:481–50310.1146/annurev-pharmtox-010611-134623 ↗
20. Nel A, Ruoslahti E, Meng H (2017) New insights into “permeability” as in the enhanced permeability and retention effect of cancer nanotherapeutics. ACS Nano 11:9567–956910.1021/acsnano.7b07214 ↗
21. Pan DC, Myerson JW, Brenner JS, Patel PN, Anselmo AC, Mitragotri S, Muzykantov V (2018) Nanoparticle properties modulate their attachment and effect on carrier red blood cells. Sci Rep 8:161510.1038/s41598-018-19897-8 ↗
22. Pang H-B, Braun GB, Friman T, Aza-Blanc P, Ruidiaz M, Sugahara KN, Teesalu T, Ruoslahti E (2014) An endocytic pathway initiated through neuropilin-1, regulated by nutrient availability. Nat Commun 5:490410.1038/ncomms5904 ↗
23. Park K (2013) Facing the truth about nanotechnology in drug delivery. ACS Nano 7:7332–7337
24. Romero EL, Morilla M-J, Regts J, Koning GA, Scherphof GL (1999) On the mechanism of hepatic transedothelial passage of large liposomes. FEBS Lett 448:193–19610.1016/S0014-5793(99)00364-6 ↗
25. Scherphof GL, Kamps JAAM (2001) The role of hepatocytes in the clearance of liposomes from the blood circulation. Prog Lipid Res 40:149–16610.1016/S0163-7827(00)00020-5 ↗
26. Smith BR, Kempen P, Bouley D, Xu A, Liu Z, Melosh N, Dai H, Sinclair R, Gambhir SS (2012) Shape matters: intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation. Nano Lett 12:3369–337710.1021/nl204175t ↗
27. Sykes EA, Chen J, Zheng G, Chan WCW (2014) Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency. ACS Nano 8:5696–570610.1021/nn500299p ↗
28. Taurin S, Nehoff H, Greish K (2012) Anticancer nanomedicine and tumor vascular permeability: where is the missing link? J Control Release 163:265–27510.1016/j.jconrel.2012.07.013 ↗
29. Thurston G, McLean JW, Rizen M, Baluk P, Haskell A, Murphy TJ, Hanahan D, McDonald DM (1998) Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. J Clin Invest 101:1401–141310.1172/JCI965 ↗
30. Wibroe PP, Anselmo AC, Nilsson PH, Sarode A, Gupta V, Urbanics R, Szebeni J, Hunter AC, Mitragotri S, Mollnes TE, Moghimi SM (2017) Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes. Nat Nanotechnol 12:589–59410.1038/nnano.2017.47 ↗
31. Wisse E, de Zanger R, van der Smissen P, McCuskey RS (1985) The liver sieve: considerations concerning the structure and function of endothelial fenestra, the sinusoidal wall and the space of Disse. Hepatology 5:683–69210.1002/hep.1840050427 ↗
32. Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK (1995) Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 55:3752–3756